mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-06 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |